United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 14, 2026 · Filed Aug 17, 2026

On Aug 14, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$498.91 for US$4.74M under a trading plan, leaving 324,443 shares. Filed Aug 17, 2026 (Form 4).

Sold
9,500 shares
Price
US$498.91 average (US$495.02 to US$500.93)
Value
US$4.74M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 14, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 14, 2026Common StockSale320US$495.02333,623Indirect
Aug 14, 2026Common StockSale414US$495.96333,209Indirect
Aug 14, 2026Common StockSale537US$497.22332,672Indirect
Aug 14, 2026Common StockSale2,130US$498.39330,542Indirect
Aug 14, 2026Common StockSale3,630US$499.30326,912Indirect
Aug 14, 2026Common StockSale2,148US$500.05324,764Indirect
Aug 14, 2026Common StockSale321US$500.93324,443Indirect

Source

View original at SEC

Related